维普中文期刊产品整合服务
111篇 您的检索式:作者名="PETRELLI F"
    题名 作者 年代 出处 被引量
1Chronic constipation in hemiplegic patients显示文摘AIM: To assess the prevalence of bowel dysfunction in hemiplegic patients, and its relationship with the site of neurological lesion, physical immobilization and pharmacotherapy. METHODS: Ninety consecutive hemiplegic patients and 81 consecutive orthopedic patients were investigated during physical motor rehabilitation in the same period, in the same center and on the same diet. All subjects were interviewed ≥ 3 mo after injury using a questionnaire inquiring about bowel habits before injury and at the time of the interview. Patients’ mobility was evaluated by the Adapted Patient Evaluation Conference System. Drugs considered for the analysis were nitrates, angiogenic converting enzyme (ACE) inhibitors, calcium antagonists, anticoagulants, antithrombotics, antidepressants, anti-epileptics. RESULTS: Mobility scores were similar in the two groups. De novo constipation (OR = 5.36) was a frequent outcome of the neurological accident. Hemiplegics showed an increased risk of straining at stool (OR: 4.33), reduced call to evacuate (OR: 4.13), sensation of incomplete evacuation (OR: 3.69), use of laxatives (OR: 3.75). Logistic regression model showed that constipation was significantly and independently associated with hemiplegia. A positive association was found between constipation and use of nitrates and antithrombotics in both groups. Constipation was not related to the site of brain injury. CONCLUSION: Chronic constipation is a possible outcome of cerebrovascular accidents occurring in 30% of neurologically stabilized hemiplegic patients. Its onset after a cerebrovascular accident appears to be independent from the injured brain hemisphere, and unrelated to physical inactivity. Pharmacological treatment with nitrates and antithrombotics may represent an independent risk factor for developing chronic constipation.F Bracci D Badiali P Pezzotti G Scivoletto U Fuoco L Di Lucente A Petrelli E Corazziari 2007World Journal of Gastroenterology2007,13,29:15
25-Fluorouracil or capecitabine in the treatment of advanced colorectal cancer:apooled-analysis of randomized trials显示文摘Petrelli F Cabiddu M Barni S 2012Med Oncol2012,29,2:1
3Biological agents alone or in combination as second-line therapy in advanced non-small-cell lung canc-er:systematic review of randomized studies显示文摘Petrelli F Borgonovo K Cabiddu M 2012Expert Rev Anticancer T-her2012,12,10:1
4Postprandial blood glucose is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus,particularly in women:lessons from the San Luigi Gonzaga Diabetes Study显示文摘Cavalot F Petrelli A Traversa M 2006J Clin Endocrinol Metab2006,91,3:1
5Prognostic value of different cut-off levels of Ki-67 in breast cancer: a systematic review and meta- analysis of 64,196 patients显示文摘Petrelli F Viale G Cabiddu M etal 2015Breast Cancer Res Treat2015,153,3:1
6Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer: a systematic review and recta-analysis 显示文摘Petrelli F De Stefani A Raspagliesi F 2014Gynecol Oncol2014,134,1:1
7Postprandial bloodglucose is a stronger predictor of cardiovascular events thanfasting blood glucose in type 2 diabetes mellitus,particularlyin women: lessons from the San Luigi Gonzaga Diabetes Study显示文摘Cavalot F Petrelli A Traversa M 2006J Clin Endocrinol Metab2006,91,3:1
8Localized augmentation of the maxillary sinus floor through a coronal approach for the placement of implants显示文摘Cavicchia F Bravi F Petrelli G 2001Int J Periodontics Restorative Dent2001,21,:1
9Erlotinib as maintenancetherapy in patients with advanced non-small cell lung cancer: apooled analysis of three randomized trials 显示文摘Petrelli F Borgonovo K Cabiddu M 2011Anticancer drugs2011,22,10:1
10FOLFIRI + bevacizumab as second-line therapy for metastatic colorectal cancer pretreated with oxaliplatin: a pooled analysis of publishied trial显示文摘Beretta GD Petrelli F Stinco S et a1 2013Med Oncol2013,30,1:1
11Postprandial blood glucose Is a stronger predictor of cardiovascular events than fasting blood glucose in type 2 diabetes mellitus, particularly in women: lessons from the San Luigi Gonzaga diabetes study显示文摘Cavalot F Petrelli A Traversa M 2006The Journal of Clini- cal Bndocfinology & Metabolism2006,91,3:1
12Early tumour shrinkage as a prognostic factor and surrogate end - point in colorectal cancer: A systematic review and pooled - analysis显示文摘Petrelli F Pietrantonio F Cremolini C 2015Eur J Cancer2015,51,7:1
13Targeted delivery for breast cancer therapy: the history of nanoparticle-albumin- bound pachtaxel显示文摘PETRELLI F BORGONOVO K BARNI S 2010Expert Opin Pharmacother2010,11,8:1
14Prognostic factors for survival with bevacizumab - based therapy in coloreetal cancer patients: a systematic review and pooled analysis of 11,585 patients 显示文摘Petrelli F Coinu A Cabiddu M 2015Med Oncol2015,32,2:1
15Efficacy of oxaliplatin-based chemotherapy + bevacizumab as first-line treatment for advanced colorectal cancer: a systematic review and pooled analysis of pub-lishedtrials显示文摘Petrelli F Coinu A Ghilardi M 2015AmJClinOncol2015,38,2:1
16Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small cell lung cancer:a meta-analysis of 13 randomized trials显示文摘Petrelli F Borgonovo K Cabiddu M 2012Clin Lung Cancer2012,13,2:1
17Efficacy of EGFR tyrosine kinase inhibitors in patients with EGFR-mutated non-small-cell lung cancer: a meta analysis of 13 randomized trials 显示文摘Petrelli F Borgonovo K Cabiddu M 2012Clin Lung Cancer2012,13,2:1
18Radical prostatectomy or radiotherapy in high-risk prostate cancer: a systematic review and metaanalysis 显示文摘Petrelli F Vavassori I Coinu A 2014Clin Genitoarin Cancer2014,12,:1
19Surgery of primary tumors in stage Ⅳ breast cancer:an updated meta-analysis of published studies with meta-re gression显示文摘Petrelli F Barni S 2012Med Oncol2012,29,5:1
20Radiotherapy with concurrent cisplatin-based doublet or weekly cisplatin for cervical cancer:A systematic review and meta-analysis 显示文摘Petrelli F De Stefani A Raspagliesi F 2014Gynecol Oncol2014,134,1:1
返回顶部 每页显示:
共6页 首页 上一页 第1页 下一页 末页 /6 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费